{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:50:33Z","timestamp":1793875833292,"version":"4.7.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["RWTH JPI Fellowhip"],"award-info":[{"award-number":["RWTH JPI Fellowhip"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC1382-Project-ID 403224013"],"award-info":[{"award-number":["CRC1382-Project-ID 403224013"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by chronic inflammation and progressive fibrosis of the biliary tree. The majority of PSC patients suffer from concomitant inflammatory bowel disease (IBD), which has been suggested to promote disease development and progression. However, the molecular mechanisms by which intestinal inflammation may aggravate cholestatic liver disease remain incompletely understood. Here, we employ an IBD-PSC mouse model to investigate the impact of colitis on bile acid metabolism and cholestatic liver injury. Unexpectedly, intestinal inflammation and barrier impairment improve acute cholestatic liver injury and result in reduced liver fibrosis in a chronic colitis model. This phenotype is independent of colitis-induced alterations of microbial bile acid metabolism but mediated via hepatocellular NF-\u03baB activation by lipopolysaccharide (LPS), which suppresses bile acid metabolism in-vitro and in-vivo. This study identifies a colitis-triggered protective circuit suppressing cholestatic liver disease and encourages multi-organ treatment strategies for PSC.<\/jats:p>","DOI":"10.1038\/s41467-023-38840-8","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T18:52:12Z","timestamp":1686077532000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2317-6959","authenticated-orcid":false,"given":"Wenfang","family":"Gui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikal Jacob","family":"Hole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Molinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Edlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin K.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Begher-Tibbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Ga\u00dfler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin V.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uthayakumar","family":"Muthukumarasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5937-0696","authenticated-orcid":false,"given":"Antje","family":"Mohs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1122-5331","authenticated-orcid":false,"given":"Julius","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7303-2650","authenticated-orcid":false,"given":"Christian J.","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3356-4115","authenticated-orcid":false,"given":"Ina","family":"Bergheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0185-1459","authenticated-orcid":false,"given":"Till","family":"Strowig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1427-5246","authenticated-orcid":false,"given":"Jan G.","family":"Hengstler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5900-8096","authenticated-orcid":false,"given":"Johannes R.","family":"Hov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7347-3085","authenticated-orcid":false,"given":"Hanns-Ulrich","family":"Marschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2762-8247","authenticated-orcid":false,"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0047-3794","authenticated-orcid":false,"given":"Kai Markus","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"key":"38840_CR1","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1053\/j.gastro.2021.07.046","volume":"161","author":"CY Ponsioen","year":"2021","unstructured":"Ponsioen, C. Y. et al. Defining primary sclerosing Cholangitis: Results from an international primary sclerosing cholangitis study group consensus process. Gastroenterology 161, 1764\u20131775.e1765 (2021).","journal-title":"Gastroenterology"},{"key":"38840_CR2","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","volume":"56","author":"K Boonstra","year":"2012","unstructured":"Boonstra, K., Beuers, U. & Ponsioen, C. Y. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review. J. Hepatol. 56, 1181\u20131188 (2012).","journal-title":"J. Hepatol."},{"key":"38840_CR3","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","volume":"382","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield, G. M., Karlsen, T. H., Lindor, K. D. & Adams, D. H. Primary sclerosing cholangitis. Lancet 382, 1587\u20131599 (2013).","journal-title":"Lancet"},{"key":"38840_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/gut.2004.046615","volume":"54","author":"EV Loftus Jr.","year":"2005","unstructured":"Loftus, E. V. Jr. et al. PSC-IBD: A unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 54, 91\u201396 (2005).","journal-title":"Gut"},{"key":"38840_CR5","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","volume":"391","author":"JK Dyson","year":"2018","unstructured":"Dyson, J. K., Beuers, U., Jones, D. E. J., Lohse, A. W. & Hudson, M. Primary sclerosing cholangitis. Lancet 391, 2547\u20132559 (2018).","journal-title":"Lancet"},{"key":"38840_CR6","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1053\/j.gastro.2021.08.032","volume":"161","author":"B Barberio","year":"2021","unstructured":"Barberio, B. et al. Prevalence of Primary sclerosing cholangitis in patients with inflammatory bowel disease: A systematic review and meta-analysis. Gastroenterology 161, 1865\u20131877 (2021).","journal-title":"Gastroenterology"},{"key":"38840_CR7","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1053\/j.gastro.2020.12.036","volume":"160","author":"AM Wijnands","year":"2021","unstructured":"Wijnands, A. M. et al. Prognostic factors for advanced colorectal neoplasia in inflammatory bowel disease: Systematic review and meta-analysis. Gastroenterology 160, 1584\u20131598 (2021).","journal-title":"Gastroenterology"},{"key":"38840_CR8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrgastro.2010.155","volume":"7","author":"F Mendes","year":"2010","unstructured":"Mendes, F. & Lindor, K. D. Primary sclerosing cholangitis: Overview and update. Nat. Rev. Gastroenterol. Hepatol. 7, 611\u2013619 (2010).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"38840_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jhep.2019.05.006","volume":"71","author":"M de Krijger","year":"2019","unstructured":"de Krijger, M., Wildenberg, M. E., de Jonge, W. J. & Ponsioen, C. Y. Return to sender: Lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitis. J. Hepatol. 71, 603\u2013615 (2019).","journal-title":"J. Hepatol."},{"key":"38840_CR10","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.cgh.2011.11.010","volume":"10","author":"A O\u2019Toole","year":"2012","unstructured":"O\u2019Toole, A. et al. Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 10, 439\u2013441 (2012).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"38840_CR11","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1053\/gast.1997.v113.pm9322530","volume":"113","author":"L Lora","year":"1997","unstructured":"Lora, L. et al. Hepatocyte tight-junctional permeability is increased in rat experimental colitis. Gastroenterology 113, 1347\u20131354 (1997).","journal-title":"Gastroenterology"},{"key":"38840_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","volume":"145","author":"JE Eaton","year":"2013","unstructured":"Eaton, J. E., Talwalkar, J. A., Lazaridis, K. N., Gores, G. J. & Lindor, K. D. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology 145, 521\u2013536 (2013).","journal-title":"Gastroenterology"},{"key":"38840_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0168-8278(98)80058-5","volume":"29","author":"K Sasatomi","year":"1998","unstructured":"Sasatomi, K., Noguchi, K., Sakisaka, S., Sata, M. & Tanikawa, K. Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. J. Hepatol. 29, 409\u2013416 (1998).","journal-title":"J. Hepatol."},{"key":"38840_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/apt.14393","volume":"47","author":"C Nordenvall","year":"2018","unstructured":"Nordenvall, C. et al. Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients. Aliment Pharm. Ther. 47, 238\u2013245 (2018).","journal-title":"Aliment Pharm. Ther."},{"key":"38840_CR15","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1136\/gut.2010.235408","volume":"60","author":"L Marelli","year":"2011","unstructured":"Marelli, L. et al. Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis? Gut 60, 1224\u20131228 (2011).","journal-title":"Gut"},{"key":"38840_CR16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cgh.2012.01.006","volume":"10","author":"U Navaneethan","year":"2012","unstructured":"Navaneethan, U. et al. Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis. Clin. Gastroenterol. Hepatol. 10, 540\u2013546 (2012).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"38840_CR17","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1136\/gutjnl-2018-316670","volume":"68","author":"L Liao","year":"2019","unstructured":"Liao, L. et al. Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis. Gut 68, 1477\u20131492 (2019).","journal-title":"Gut"},{"key":"38840_CR18","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/s42255-021-00452-1","volume":"3","author":"KM Schneider","year":"2021","unstructured":"Schneider, K. M. et al. Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling. Nat. Metab. 3, 1228\u20131241 (2021).","journal-title":"Nat. Metab."},{"key":"38840_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0168-8278(03)00214-9","volume":"39","author":"MH Schoemaker","year":"2003","unstructured":"Schoemaker, M. H. et al. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. J. Hepatol. 39, 153\u2013161 (2003).","journal-title":"J. Hepatol."},{"key":"38840_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature02924","volume":"431","author":"E Pikarsky","year":"2004","unstructured":"Pikarsky, E. et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431, 461\u2013466 (2004).","journal-title":"Nature"},{"key":"38840_CR21","doi-asserted-by":"publisher","unstructured":"Bisgaard, T. H., Allin, K. H., Keefer, L., Ananthakrishnan, A. N. & Jess, T. Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment. Nat. Rev. Gastroenterol. Hepatol. https:\/\/doi.org\/10.1038\/s41575-022-00634-6 (2022).","DOI":"10.1038\/s41575-022-00634-6"},{"key":"38840_CR22","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/hep.31228","volume":"72","author":"A Isaacs-Ten","year":"2020","unstructured":"Isaacs-Ten, A. et al. Intestinal microbiome-macrophage crosstalk contributes to cholestatic liver disease by promoting intestinal permeability in mice. Hepatology 72, 2090\u20132108 (2020).","journal-title":"Hepatology"},{"key":"38840_CR23","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1053\/j.gastro.2020.07.001","volume":"159","author":"P Vijayvargiya","year":"2020","unstructured":"Vijayvargiya, P. et al. Combined fasting serum C4 and primary bile acids from a single stool sample to diagnose bile acid diarrhea. Gastroenterology 159, 1952\u20131954.e1952 (2020).","journal-title":"Gastroenterology"},{"key":"38840_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1053\/j.gastro.2011.10.028","volume":"142","author":"S Modica","year":"2012","unstructured":"Modica, S. et al. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis. Gastroenterology 142, 355\u2013365.e351-354 (2012).","journal-title":"Gastroenterology"},{"key":"38840_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1053\/gast.1996.v111.pm8698199","volume":"111","author":"RM Green","year":"1996","unstructured":"Green, R. M., Beier, D. & Gollan, J. L. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology 111, 193\u2013198 (1996).","journal-title":"Gastroenterology"},{"key":"38840_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ccr.2006.12.016","volume":"11","author":"T Luedde","year":"2007","unstructured":"Luedde, T. et al. Deletion of NEMO\/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11, 119\u2013132 (2007).","journal-title":"Cancer Cell"},{"key":"38840_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/j.gastro.2011.09.051","volume":"142","author":"T Moustafa","year":"2012","unstructured":"Moustafa, T. et al. Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury. Gastroenterology 142, 140\u2013151.e112 (2012).","journal-title":"Gastroenterology"},{"key":"38840_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jhep.2019.04.012","volume":"71","author":"T Nishio","year":"2019","unstructured":"Nishio, T. et al. Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice. J. Hepatol. 71, 573\u2013585 (2019).","journal-title":"J. Hepatol."},{"key":"38840_CR29","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","volume":"151","author":"AK Lunder","year":"2016","unstructured":"Lunder, A. K. et al. Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease. Gastroenterology 151, 660\u2013669 e664 (2016).","journal-title":"Gastroenterology"},{"key":"38840_CR30","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/ibd.21699","volume":"18","author":"KK J\u00f8rgensen","year":"2012","unstructured":"J\u00f8rgensen, K. K. et al. Inflammatory bowel disease in patients with primary sclerosing cholangitis: Clinical characterization in liver transplanted and nontransplanted patients. Inflamm. Bowel Dis. 18, 536\u2013545 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"38840_CR31","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1136\/gutjnl-2016-313681","volume":"67","author":"EM de Vries","year":"2018","unstructured":"de Vries, E. M. et al. A novel prognostic model for transplant-free survival in primary sclerosing cholangitis. Gut 67, 1864\u20131869 (2018).","journal-title":"Gut"},{"key":"38840_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jhep.2012.02.034","volume":"57","author":"M Janse","year":"2012","unstructured":"Janse, M., Lamberts, L. E., Verdonk, R. C. & Weersma, R. K. IBD is associated with an increase in carcinoma in PSC irrespective of the presence of dominant bile duct stenosis. J. Hepatol. 57, 473\u2013474 (2012).","journal-title":"J. Hepatol."},{"key":"38840_CR33","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1365-2036.2012.05063.x","volume":"35","author":"U Navaneethan","year":"2012","unstructured":"Navaneethan, U., Venkatesh, P. G., Lashner, B. A., Shen, B. & Kiran, R. P. The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis. Aliment Pharm. Ther. 35, 1045\u20131053 (2012).","journal-title":"Aliment Pharm. Ther."},{"key":"38840_CR34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","volume":"4","author":"N Nakamoto","year":"2019","unstructured":"Nakamoto, N. et al. Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis. Nat. Microbiol. 4, 492\u2013503 (2019).","journal-title":"Nat. Microbiol."},{"key":"38840_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-2006-933559","volume":"26","author":"CA O\u2019Mahony","year":"2006","unstructured":"O\u2019Mahony, C. A. & Vierling, J. M. Etiopathogenesis of primary sclerosing cholangitis. Semin Liver Dis. 26, 3\u201321 (2006).","journal-title":"Semin Liver Dis."},{"key":"38840_CR36","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0016-5085(91)90224-9","volume":"100","author":"SN Lichtman","year":"1991","unstructured":"Lichtman, S. N., Keku, J., Schwab, J. H. & Sartor, R. B. Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology 100, 513\u2013519 (1991).","journal-title":"Gastroenterology"},{"key":"38840_CR37","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1111\/j.1478-3231.2011.02635.x","volume":"31","author":"T Mueller","year":"2011","unstructured":"Mueller, T. et al. Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis. Liver Int 31, 1574\u20131588 (2011).","journal-title":"Liver Int"},{"key":"38840_CR38","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.cgh.2011.08.027","volume":"9","author":"JH Ngu","year":"2011","unstructured":"Ngu, J. H., Gearry, R. B., Wright, A. J. & Stedman, C. A. Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis. Clin. Gastroenterol. Hepatol. 9, 1092\u20131097 (2011).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"38840_CR39","doi-asserted-by":"publisher","first-page":"581","DOI":"10.7326\/0003-4819-102-5-581","volume":"102","author":"A Wee","year":"1985","unstructured":"Wee, A. & Ludwig, J. Pericholangitis in chronic ulcerative colitis: Primary sclerosing cholangitis of the small bile ducts? Ann. Intern Med 102, 581\u2013587 (1985).","journal-title":"Ann. Intern Med"},{"key":"38840_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/hep.1840110103","volume":"11","author":"M Rabinovitz","year":"1990","unstructured":"Rabinovitz, M. et al. Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects. Hepatology 11, 7\u201311 (1990).","journal-title":"Hepatology"},{"key":"38840_CR41","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/j.1440-1746.2003.03333.x","volume":"19","author":"Y Numata","year":"2004","unstructured":"Numata, Y., Tazuma, S., Nishioka, T., Ueno, Y. & Chayama, K. Immune response in mouse experimental cholangitis associated with colitis induced by dextran sulfate sodium. J. Gastroenterol. Hepatol. 19, 910\u2013915 (2004).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"38840_CR42","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/hep.27982","volume":"62","author":"KM Schneider","year":"2015","unstructured":"Schneider, K. M. et al. CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis. Hepatology 62, 1405\u20131416 (2015).","journal-title":"Hepatology"},{"key":"38840_CR43","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.jhep.2011.02.035","volume":"55","author":"E Gabele","year":"2011","unstructured":"Gabele, E. et al. DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. J. Hepatol. 55, 1391\u20131399 (2011).","journal-title":"J. Hepatol."},{"key":"38840_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5573","volume":"5","author":"X Zhou","year":"2014","unstructured":"Zhou, X. et al. PPARalpha-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis. Nat. Commun. 5, 4573 (2014).","journal-title":"Nat. Commun."},{"key":"38840_CR45","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/mi.2012.33","volume":"5","author":"A Batra","year":"2012","unstructured":"Batra, A. et al. Mesenteric fat - control site for bacterial translocation in colitis? Mucosal. Immunol. 5, 580\u2013591 (2012).","journal-title":"Mucosal. Immunol."},{"key":"38840_CR46","doi-asserted-by":"publisher","first-page":"237ra266","DOI":"10.1126\/scitranslmed.3008618","volume":"6","author":"ML Balmer","year":"2014","unstructured":"Balmer, M. L. et al. The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. Sci. Transl. Med. 6, 237ra266 (2014).","journal-title":"Sci. Transl. Med."},{"key":"38840_CR47","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1002\/hep.510280625","volume":"28","author":"TA Vos","year":"1998","unstructured":"Vos, T. A. et al. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 28, 1637\u20131644 (1998).","journal-title":"Hepatology"},{"key":"38840_CR48","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1172\/JCI1680","volume":"101","author":"M Trauner","year":"1998","unstructured":"Trauner, M., Arrese, M., Lee, H., Boyer, J. L. & Karpen, S. J. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J. Clin. Invest 101, 2092\u20132100 (1998).","journal-title":"J. Clin. Invest"},{"key":"38840_CR49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0022-2275(20)37610-0","volume":"37","author":"KR Feingold","year":"1996","unstructured":"Feingold, K. R., Spady, D. K., Pollock, A. S., Moser, A. H. & Grunfeld, C. Endotoxin, TNF, and IL-1 decrease cholesterol 7 alpha-hydroxylase mRNA levels and activity. J. Lipid Res. 37, 223\u2013228 (1996).","journal-title":"J. Lipid Res."},{"key":"38840_CR50","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1053\/gast.1997.v113.pm9322528","volume":"113","author":"TA Vos","year":"1997","unstructured":"Vos, T. A. et al. Differential effects of nitric oxide synthase inhibitors on endotoxin-induced liver damage in rats. Gastroenterology 113, 1323\u20131333 (1997).","journal-title":"Gastroenterology"},{"key":"38840_CR51","doi-asserted-by":"publisher","first-page":"e25942","DOI":"10.1371\/journal.pone.0025942","volume":"6","author":"H Ehlken","year":"2011","unstructured":"Ehlken, H. et al. Hepatocyte IKK2 protects Mdr2\u2212\/\u2212 mice from chronic liver failure. PLoS One 6, e25942 (2011).","journal-title":"PLoS One"},{"key":"38840_CR52","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jhep.2019.05.030","volume":"71","author":"F Glaser","year":"2019","unstructured":"Glaser, F. et al. Liver infiltrating T cells regulate bile acid metabolism in experimental cholangitis. J. Hepatol. 71, 783\u2013792 (2019).","journal-title":"J. Hepatol."},{"key":"38840_CR53","doi-asserted-by":"publisher","first-page":"21805","DOI":"10.1074\/jbc.C000275200","volume":"275","author":"JH Miyake","year":"2000","unstructured":"Miyake, J. H., Wang, S. L. & Davis, R. A. Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7alpha-hydroxylase. J. Biol. Chem. 275, 21805\u201321808 (2000).","journal-title":"J. Biol. Chem."},{"key":"38840_CR54","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","volume":"68","author":"MH Chapman","year":"2019","unstructured":"Chapman, M. H. et al. British society of gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut 68, 1356\u20131378 (2019).","journal-title":"Gut"},{"key":"38840_CR55","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cgh.2019.05.013","volume":"18","author":"KD Lynch","year":"2020","unstructured":"Lynch, K. D. et al. Effects of Vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases. Clin. Gastroenterol. Hepatol. 18, 179\u2013187.e176 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"38840_CR56","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"TH Karlsen","year":"2017","unstructured":"Karlsen, T. H., Folseraas, T., Thorburn, D. & Vesterhus, M. Primary sclerosing cholangitis - a comprehensive review. J. Hepatol. 67, 1298\u20131323 (2017).","journal-title":"J. Hepatol."},{"key":"38840_CR57","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.toxlet.2019.05.004","volume":"312","author":"J Jiang","year":"2019","unstructured":"Jiang, J. et al. Human 3D multicellular microtissues: An upgraded model for the in vitro mechanistic investigation of inflammation-associated drug toxicity. Toxicol. Lett. 312, 34\u201344 (2019).","journal-title":"Toxicol. Lett."},{"key":"38840_CR58","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00428-020-02982-7","volume":"478","author":"C Lang-Schwarz","year":"2021","unstructured":"Lang-Schwarz, C. et al. Maximizing the diagnostic information from biopsies in chronic inflammatory bowel diseases: recommendations from the Erlangen International Consensus Conference on Inflammatory Bowel Diseases and presentation of the IBD-DCA score as a proposal for a new index for histologic activity assessment in ulcerative colitis and Crohn\u2019s disease. Virchows Arch. 478, 581\u2013594 (2021).","journal-title":"Virchows Arch."},{"key":"38840_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mimet.2017.10.015","volume":"144","author":"L Krych","year":"2018","unstructured":"Krych, L. et al. Have you tried spermine? A rapid and cost-effective method to eliminate dextran sodium sulfate inhibition of PCR and RT-PCR. J. Microbiol Methods 144, 1\u20137 (2018).","journal-title":"J. Microbiol Methods"},{"key":"38840_CR60","doi-asserted-by":"publisher","first-page":"61","DOI":"10.7171\/jbt.18-2903-001","volume":"29","author":"B Oldak","year":"2018","unstructured":"Oldak, B., Cruz-Rivera, M., Flisser, A. & Mendlovic, F. RNA Purity, Real-Time PCR sensitivity, and colon segment influence mRNA relative expression in murine dextran sodium sulfate experimental colitis. J. Biomol. Tech. 29, 61\u201370 (2018).","journal-title":"J. Biomol. Tech."},{"key":"38840_CR61","doi-asserted-by":"publisher","unstructured":"Viennois, E., Tahsin, A. & Merlin, D. Purification of Total RNA from DSS-treated Murine Tissue via Lithium Chloride Precipitation. Bio. Protoc. 8, https:\/\/doi.org\/10.21769\/BioProtoc.2829 (2018).","DOI":"10.21769\/BioProtoc.2829"},{"key":"38840_CR62","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/hep.22950","volume":"50","author":"KR Karlmark","year":"2009","unstructured":"Karlmark, K. R. et al. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50, 261\u2013274 (2009).","journal-title":"Hepatology"},{"key":"38840_CR63","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cmet.2015.07.009","volume":"22","author":"V Tremaroli","year":"2015","unstructured":"Tremaroli, V. et al. Roux-en-Y Gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 22, 228\u2013238 (2015).","journal-title":"Cell Metab."},{"key":"38840_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31312-5","volume":"13","author":"KM Schneider","year":"2022","unstructured":"Schneider, K. M. et al. Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment. Nat. Commun. 13, 3964 (2022).","journal-title":"Nat. Commun."},{"key":"38840_CR65","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/hep.28829","volume":"64","author":"B Lelouvier","year":"2016","unstructured":"Lelouvier, B. et al. Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis. Hepatology 64, 2015\u20132027 (2016).","journal-title":"Hepatology"},{"key":"38840_CR66","doi-asserted-by":"publisher","first-page":"e0142334","DOI":"10.1371\/journal.pone.0142334","volume":"10","author":"J Lluch","year":"2015","unstructured":"Lluch, J. et al. The Characterization of novel tissue microbiota using an optimized 16S metagenomic sequencing pipeline. PLoS One 10, e0142334 (2015).","journal-title":"PLoS One"},{"key":"38840_CR67","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/trf.13477","volume":"56","author":"S Paisse","year":"2016","unstructured":"Paisse, S. et al. Comprehensive description of blood microbiome from healthy donors assessed by 16S targeted metagenomic sequencing. Transfusion 56, 1138\u20131147 (2016).","journal-title":"Transfusion"},{"key":"38840_CR68","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.12688\/f1000research.7035.1","volume":"4","author":"MI Love","year":"2015","unstructured":"Love, M. I., Anders, S., Kim, V. & Huber, W. RNA-Seq workflow: Gene-level exploratory analysis and differential expression. F1000Res. 4, 1070 (2015).","journal-title":"F1000Res."},{"key":"38840_CR69","doi-asserted-by":"publisher","first-page":"e1007664","DOI":"10.1371\/journal.pcbi.1007664","volume":"16","author":"MI Love","year":"2020","unstructured":"Love, M. I. et al. Tximeta: Reference sequence checksums for provenance identification in RNA-seq. PLoS Comput. Biol. 16, e1007664 (2020).","journal-title":"PLoS Comput. Biol."},{"key":"38840_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"38840_CR71","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"38840_CR72","first-page":"275","volume":"18","author":"M Stephens","year":"2017","unstructured":"Stephens, M. False discovery rates: A new deal. Biostatistics 18, 275\u2013294 (2017).","journal-title":"Biostatistics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-38840-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-38840-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-38840-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T18:57:29Z","timestamp":1702580249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-38840-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["38840"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-38840-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"25 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3304"}}